Gracell Biotechnologies Inc.: current_liabilities
| Value | {"amount": 26728000, "concept": "us-gaap:LiabilitiesCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2023-06-30) |
| Status | current |
| Entity | Gracell Biotechnologies Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T18:23:15.844735+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/d4aafbd3-8f24-48e8-9633-df7a1c88bff7
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001104659-23-091460Retrieved: 2026-08-19T18:23:15.844735+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001826492/current-liabilities/2023-06-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/d4aafbd3-8f24-48e8-9633-df7a1c88bff7
History
- supersedes {"unit": "CNY", "value": 193816000, "concept": "us-gaap:LiabilitiesCurrent"} (evidence 0001104659-23-091460)